GLOBAL BIO-PHARMA COMPUTE TIDES: 10 CASE STUDIES × KAI.COM SCHEDULING SOVEREIGNTY

Ten Core Case Studies at a Glance

案例 / Case Study

Mode

Peak/Avg

Annual Vol KAI.com 核心价值 / KAI.com Core Value ①

mRNA Pandemic Response Moderna(美)+BioNTech(德) 危机脉冲 Crisis Pulse US / Germany 200×

On-demand burst

“Pandemic Compute Insurance” contract ②

DeepMind Protein Universe 伦敦 Isomorphic Labs 持续+批次 Continuous+Batch London, UK 3×

GPU·h 5M-10M GPU·hours

Compute forwards, across 30 DCs in 15 countries ③

China Million Genomes

BGI / CNGB (China) 5×

3M per cohort

Domestic cross-DC routing; commercialization during gaps ④

India Generic Patent Cliff

Hyderabad, India 4×

1.5M / year

Patent calendar converted to compute futures calendar ⑤

Swiss Virtual Screening Race Roche · Novartis 并行冲刺 Parallel Sprint Basel, Switzerland 8×

114M / year

P0/P1/P2/P3 stratified tier pricing ⑥

Japan Aging Medicine

Daiichi Sankyo / RIKEN 2×

20M+

Premium on “ESG-tagged green compute” ⑦

Africa Drug Resistance 非洲CDC · WHO 雨季脉冲 Rainy Season ×3 Africa CDC / WHO 3×

500K / year

Edge inference nodes + philanthropic compute pools KAI.com | Global Bio-Pharma Compute Sovereignty

案例 / Case Study

Mode

Peak/Avg

Annual Vol KAI.com 核心价值 / KAI.com Core Value ⑧

Singapore Precision Oncology NCCS · A*STAR 72h SLA 硬约束 Hard SLA Singapore 3×

8M / year

5-nation emergency compute mutual insurance protocol ⑨

BioNTech Personalized Vaccine

Mainz / Global Hospitals 1.5×

70M / year

48h tracking smart contract, migration across 5 DCs ⑩

Brazil Tropical Diseases & Venom Butantan · Fiocruz 供给瓶颈 Supply Bottleneck Brazil —

6M+ / year

South-South compute swap (barter clearing)

Core Argument: Why Bio-Pharma is KAI.com’s “Base Yield Layer”

Defense compute represents sharp pulses (violent spikes and sudden drops), while bio-pharma represents tides (regular, cross-seasonal, and cross-border cyclical patterns).

The first rule of market making: find the buyer who is willing to pay transaction fees consistently. Bio-pharma is that exact buyer. 为什么药企不能自建算力？ Why Pharma Giants Cannot Build Their Own Infrastructure

Pfizer ($58B Revenue): Building a 5,000 H100 cluster costs only 2.6% of revenue, but average utilization remains under 30%.

Moderna: Building own clusters would mean 99% idle time with zero demand during non-pandemic periods.

BioNTech ($4B Revenue): Requires 70M GPU·h/year. Self-building would consume 20% of total revenue, which is financially unfeasible.

Industry Reality: Only Roche, Pfizer, and Novartis can barely afford self-building, yet their utilization rates never exceed 50%. • • • • KAI.com | Global Bio-Pharma Compute Sovereignty Elastic Insurance Global Tidal Arbitrage Sovereign Compliance Routing Stratified Tiered Pricing South-South Barter Clearing

KAI.com’s Fivefold Irreplaceable Value Propositions

BioNTech doesn’t need to maintain massive idle clusters for pandemics. KAI.com provides instant burst capacity via the aggregate elasticity of 40+ data centers worldwide.

As Europe enters midnight and power prices drop, latency-insensitive tasks are automatically injected. Pharma firms enjoy optimal costs without needing to manage the underlying complexity.

Ensures Chinese genomic data stays within China, EU data complies with GDPR zones, and African data is processed locally via edge nodes without leaving the continent.

Granular pricing architecture: P0 Emergency (3×), P1 Competitive (2×), P2 Routine (1×), and P3 Fragmented (0.3×). Maximizes revenue from the exact same GPU asset across different periods.

Brazil’s Butantan Institute can leverage its idle winter-night GPU capacity to directly barter for India CSIR’s daytime compute, achieving efficient non-monetary clearing. KAI.com | Global Bio-Pharma Compute Sovereignty

When the presence of KAI.com dictates whether BioNTech can design a pandemic vaccine within 48 hours, whether a Singaporean cancer patient can obtain an AI report within 72 hours, or whether drug resistance in Africa can be detected within a week—KAI.com ceases to be just a company. It becomes the foundational infrastructure for global public health. KAI.com | Global Bio-Pharma Compute Sovereignty